

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 5.67664030 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.57069737 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.57069737 |
| 4 | nuclear pore organization (GO:0006999) | 4.78708111 |
| 5 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.70834624 |
| 6 | Golgi to endosome transport (GO:0006895) | 4.50436476 |
| 7 | pore complex assembly (GO:0046931) | 4.23948650 |
| 8 | pyrimidine dimer repair (GO:0006290) | 4.18929204 |
| 9 | dosage compensation (GO:0007549) | 4.17767053 |
| 10 | COPII vesicle coating (GO:0048208) | 4.08046118 |
| 11 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.92726304 |
| 12 | intestinal cholesterol absorption (GO:0030299) | 3.84623476 |
| 13 | neural tube formation (GO:0001841) | 3.81542859 |
| 14 | mitotic sister chromatid cohesion (GO:0007064) | 3.80979455 |
| 15 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.80328617 |
| 16 | interkinetic nuclear migration (GO:0022027) | 3.75560345 |
| 17 | positive regulation of histone deacetylation (GO:0031065) | 3.73696567 |
| 18 | macroautophagy (GO:0016236) | 3.68703532 |
| 19 | vesicle coating (GO:0006901) | 3.66958098 |
| 20 | iron ion import (GO:0097286) | 3.62713420 |
| 21 | oocyte development (GO:0048599) | 3.58929254 |
| 22 | ether lipid metabolic process (GO:0046485) | 3.58795025 |
| 23 | protein targeting to Golgi (GO:0000042) | 3.58485191 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57922494 |
| 25 | peptidyl-lysine dimethylation (GO:0018027) | 3.55973228 |
| 26 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.51168228 |
| 27 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.49621811 |
| 28 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.45609433 |
| 29 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.40797514 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37455751 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37455751 |
| 32 | positive regulation of nuclease activity (GO:0032075) | 3.37014419 |
| 33 | lysine metabolic process (GO:0006553) | 3.36469755 |
| 34 | lysine catabolic process (GO:0006554) | 3.36469755 |
| 35 | establishment of protein localization to Golgi (GO:0072600) | 3.33262414 |
| 36 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.32153527 |
| 37 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 3.29704350 |
| 38 | vesicle transport along microtubule (GO:0047496) | 3.28114706 |
| 39 | tricarboxylic acid metabolic process (GO:0072350) | 3.27918763 |
| 40 | histone H3-K9 methylation (GO:0051567) | 3.27265413 |
| 41 | definitive hemopoiesis (GO:0060216) | 3.23259934 |
| 42 | regulation of centriole replication (GO:0046599) | 3.23237444 |
| 43 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.22860496 |
| 44 | corticosteroid receptor signaling pathway (GO:0031958) | 3.18485736 |
| 45 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.17272843 |
| 46 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.17272843 |
| 47 | valine metabolic process (GO:0006573) | 3.17233461 |
| 48 | peptidyl-lysine methylation (GO:0018022) | 3.16147643 |
| 49 | histone H3-K4 trimethylation (GO:0080182) | 3.16104542 |
| 50 | peptidyl-lysine trimethylation (GO:0018023) | 3.12369499 |
| 51 | protein targeting to lysosome (GO:0006622) | 3.10426191 |
| 52 | establishment of protein localization to vacuole (GO:0072666) | 3.10426191 |
| 53 | protein targeting to vacuole (GO:0006623) | 3.10426191 |
| 54 | growth hormone receptor signaling pathway (GO:0060396) | 3.07184621 |
| 55 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.06060206 |
| 56 | positive regulation of glycolytic process (GO:0045821) | 3.05995396 |
| 57 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.05362005 |
| 58 | negative regulation of cell killing (GO:0031342) | 3.05362005 |
| 59 | regulation of establishment of cell polarity (GO:2000114) | 3.04592419 |
| 60 | early endosome to late endosome transport (GO:0045022) | 3.04083988 |
| 61 | cellular response to ethanol (GO:0071361) | 3.02698878 |
| 62 | regulation of nuclease activity (GO:0032069) | 3.01958823 |
| 63 | histone mRNA catabolic process (GO:0071044) | 3.01624285 |
| 64 | negative regulation of cell size (GO:0045792) | 2.99649462 |
| 65 | ER-nucleus signaling pathway (GO:0006984) | 2.98734595 |
| 66 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.97678411 |
| 67 | acrosome assembly (GO:0001675) | 2.97146475 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.96389133 |
| 69 | endoplasmic reticulum organization (GO:0007029) | 2.96086638 |
| 70 | cellular response to prostaglandin stimulus (GO:0071379) | 2.94803954 |
| 71 | protein retention in ER lumen (GO:0006621) | 2.89640264 |
| 72 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89593337 |
| 73 | germ cell migration (GO:0008354) | 2.89497004 |
| 74 | nucleus localization (GO:0051647) | 2.89019483 |
| 75 | cellular response to unfolded protein (GO:0034620) | 2.87820769 |
| 76 | ribonucleoprotein complex disassembly (GO:0032988) | 2.86468928 |
| 77 | histone lysine demethylation (GO:0070076) | 2.86220103 |
| 78 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.86219070 |
| 79 | histone H3-K9 demethylation (GO:0033169) | 2.85771869 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85257609 |
| 81 | histone H3-K9 modification (GO:0061647) | 2.82495962 |
| 82 | phospholipid dephosphorylation (GO:0046839) | 2.77478763 |
| 83 | histone demethylation (GO:0016577) | 2.75135741 |
| 84 | microtubule anchoring (GO:0034453) | 2.73998620 |
| 85 | N-glycan processing (GO:0006491) | 2.73808150 |
| 86 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.72294773 |
| 87 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.70798960 |
| 88 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.69970527 |
| 89 | cellular response to topologically incorrect protein (GO:0035967) | 2.69686539 |
| 90 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.69281265 |
| 91 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.69281265 |
| 92 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.69281265 |
| 93 | cellular response to growth hormone stimulus (GO:0071378) | 2.68931700 |
| 94 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.68159090 |
| 95 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.67746193 |
| 96 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.67708013 |
| 97 | succinate metabolic process (GO:0006105) | 2.67114602 |
| 98 | histone lysine methylation (GO:0034968) | 2.66306324 |
| 99 | regulation of centrosome duplication (GO:0010824) | 2.65405268 |
| 100 | positive regulation of protein deacetylation (GO:0090312) | 2.63365857 |
| 101 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.62859817 |
| 102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.62412318 |
| 103 | hepatocyte apoptotic process (GO:0097284) | 2.61674286 |
| 104 | cellular ketone body metabolic process (GO:0046950) | 2.61544611 |
| 105 | alpha-linolenic acid metabolic process (GO:0036109) | 2.60651965 |
| 106 | regulation of glycolytic process (GO:0006110) | 2.60343125 |
| 107 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59512541 |
| 108 | Golgi to plasma membrane transport (GO:0006893) | 2.59301217 |
| 109 | intraciliary transport (GO:0042073) | 2.58700386 |
| 110 | exocrine pancreas development (GO:0031017) | 2.58273937 |
| 111 | regulation of histone H3-K27 methylation (GO:0061085) | 2.58100439 |
| 112 | androgen receptor signaling pathway (GO:0030521) | 2.57345780 |
| 113 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.55400505 |
| 114 | dorsal/ventral axis specification (GO:0009950) | 2.54488362 |
| 115 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.54207002 |
| 116 | gene silencing by RNA (GO:0031047) | 2.51470001 |
| 117 | snRNA transcription (GO:0009301) | 2.50494727 |
| 118 | protein K11-linked deubiquitination (GO:0035871) | 2.49425976 |
| 119 | microtubule nucleation (GO:0007020) | 2.49091872 |
| 120 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.48931481 |
| 121 | protein dealkylation (GO:0008214) | 2.48444896 |
| 122 | protein demethylation (GO:0006482) | 2.48444896 |
| 123 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.48180756 |
| 124 | phosphatidylinositol phosphorylation (GO:0046854) | 2.48098186 |
| 125 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.47431197 |
| 126 | maternal placenta development (GO:0001893) | 2.47349219 |
| 127 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.47019422 |
| 128 | mRNA modification (GO:0016556) | 2.46908164 |
| 129 | glycoprotein catabolic process (GO:0006516) | 2.46535759 |
| 130 | negative regulation of fatty acid transport (GO:2000192) | 2.46370491 |
| 131 | sequestering of metal ion (GO:0051238) | 2.45343112 |
| 132 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.43358405 |
| 133 | Golgi organization (GO:0007030) | 2.43116480 |
| 134 | Golgi to plasma membrane protein transport (GO:0043001) | 2.42877702 |
| 135 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.42649806 |
| 136 | beta-amyloid metabolic process (GO:0050435) | 2.41958870 |
| 137 | stress granule assembly (GO:0034063) | 2.41897103 |
| 138 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.41682469 |
| 139 | response to prostaglandin E (GO:0034695) | 2.41247520 |
| 140 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.41234861 |
| 141 | regulation of carbohydrate catabolic process (GO:0043470) | 2.40544973 |
| 142 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 2.40544973 |
| 143 | negative regulation of histone methylation (GO:0031061) | 2.39938563 |
| 144 | negative regulation of complement activation (GO:0045916) | 2.39684583 |
| 145 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.39356226 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.38534611 |
| 147 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.38407097 |
| 148 | positive regulation of hormone metabolic process (GO:0032352) | 2.37351161 |
| 149 | establishment of nucleus localization (GO:0040023) | 2.36156570 |
| 150 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.36023993 |
| 151 | endocrine pancreas development (GO:0031018) | 2.35614391 |
| 152 | response to endoplasmic reticulum stress (GO:0034976) | 2.35511662 |
| 153 | negative regulation of TOR signaling (GO:0032007) | 2.35487598 |
| 154 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.34616861 |
| 155 | cellular response to antibiotic (GO:0071236) | 2.33884172 |
| 156 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.32921566 |
| 157 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.32515770 |
| 158 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.32348600 |
| 159 | regulation of histone deacetylation (GO:0031063) | 2.31868443 |
| 160 | prostate gland growth (GO:0060736) | 2.31747554 |
| 161 | necroptotic process (GO:0070266) | 2.30544174 |
| 162 | nucleobase catabolic process (GO:0046113) | 2.28969011 |
| 163 | phospholipid homeostasis (GO:0055091) | 2.28671907 |
| 164 | negative regulation of heart growth (GO:0061117) | 2.27235908 |
| 165 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.27235908 |
| 166 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.26969943 |
| 167 | fibroblast migration (GO:0010761) | 2.21638535 |
| 168 | regulation of RNA export from nucleus (GO:0046831) | 2.21368835 |
| 169 | regulation of growth hormone secretion (GO:0060123) | 2.20933600 |
| 170 | cellular response to vitamin D (GO:0071305) | 2.19824462 |
| 171 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.19661385 |
| 172 | regulation of protein deacetylation (GO:0090311) | 2.18384729 |
| 173 | positive regulation of B cell differentiation (GO:0045579) | 2.14928201 |
| 174 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 2.14383540 |
| 175 | 4-hydroxyproline metabolic process (GO:0019471) | 2.14302554 |
| 176 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.14237010 |
| 177 | ketone body metabolic process (GO:1902224) | 2.12717283 |
| 178 | protein localization to Golgi apparatus (GO:0034067) | 2.11921502 |
| 179 | glial cell proliferation (GO:0014009) | 2.09577809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.26461066 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.13958472 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.04338870 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.61365236 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.26201600 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.07346962 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.04430681 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90601203 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90071062 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.72608077 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.68546965 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.65901255 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.56275142 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.35112329 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.23448512 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22042061 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13388794 |
| 18 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.05587926 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02701568 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99389118 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94061665 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94052025 |
| 23 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.90383100 |
| 24 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.86617267 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85480683 |
| 26 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.84677644 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.83742811 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80241359 |
| 29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.78355829 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77594621 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76784805 |
| 32 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.76759965 |
| 33 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.75508420 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.75448465 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74195597 |
| 36 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.73976947 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70155485 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65682295 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.64548859 |
| 40 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.64281664 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62315202 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62089082 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.57703856 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57267419 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55252535 |
| 46 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.55070144 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54993959 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52915774 |
| 49 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.52821546 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51477646 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50728403 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50541194 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49990371 |
| 54 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47120938 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.46946243 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.46653092 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45270073 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45053843 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45053843 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43858463 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42152329 |
| 62 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41912459 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39509365 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39118129 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38309462 |
| 66 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36368604 |
| 67 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36368604 |
| 68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.36117000 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35787860 |
| 70 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.35746108 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34929179 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34755426 |
| 73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34729665 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34246043 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32992767 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32951658 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.32945980 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32796033 |
| 79 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.32693817 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32605451 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32275443 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31629992 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31461110 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31331874 |
| 85 | MYB_26560356_Chip-Seq_TH2_Human | 1.31319468 |
| 86 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.31161515 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30694210 |
| 88 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.30673208 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30606823 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29367651 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28824479 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28194606 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27587422 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.27198328 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26517944 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26248951 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24973735 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23990078 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.23461136 |
| 100 | MYB_26560356_Chip-Seq_TH1_Human | 1.22922158 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22750871 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22479237 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22479218 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21881211 |
| 105 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21029976 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 1.19034526 |
| 107 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17749553 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17615823 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17025437 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15566158 |
| 111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15148941 |
| 112 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14978963 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14379425 |
| 114 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14188305 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14158053 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13953461 |
| 117 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13905569 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13643268 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13230176 |
| 120 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12848406 |
| 121 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11500714 |
| 122 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11275133 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10872502 |
| 124 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10832087 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10581262 |
| 126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09999161 |
| 127 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09920993 |
| 128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.09014800 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08939424 |
| 130 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08725334 |
| 131 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.08574594 |
| 132 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08465540 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08393380 |
| 134 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08279803 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07599002 |
| 136 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.06889316 |
| 137 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.06844210 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06354294 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05769934 |
| 140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05116887 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05092456 |
| 142 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04181792 |
| 143 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04072489 |
| 144 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02737392 |
| 145 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02506394 |
| 146 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02430659 |
| 147 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01987699 |
| 148 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01614540 |
| 149 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00989417 |
| 150 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00972754 |
| 151 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00911207 |
| 152 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00292591 |
| 153 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00173574 |
| 154 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99950917 |
| 155 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99541980 |
| 156 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99526273 |
| 157 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98760614 |
| 158 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97596626 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97575269 |
| 160 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97226573 |
| 161 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95619566 |
| 162 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94987404 |
| 163 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94629762 |
| 164 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93800000 |
| 165 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93489349 |
| 166 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92686017 |
| 167 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92493314 |
| 168 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92223585 |
| 169 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92032616 |
| 170 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91065946 |
| 171 | * PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.90494283 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90236618 |
| 173 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.89986799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.69895232 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.48896742 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.31408874 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.28814198 |
| 5 | MP0003252_abnormal_bile_duct | 3.11185591 |
| 6 | MP0005248_abnormal_Harderian_gland | 3.07016230 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.99671565 |
| 8 | MP0006054_spinal_hemorrhage | 2.89895714 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.57278472 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.55390741 |
| 11 | MP0002928_abnormal_bile_duct | 2.53945539 |
| 12 | MP0005365_abnormal_bile_salt | 2.44105337 |
| 13 | MP0010678_abnormal_skin_adnexa | 2.43632283 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.36331207 |
| 15 | MP0000383_abnormal_hair_follicle | 2.32195448 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.31119697 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.06206649 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.04779719 |
| 19 | MP0003787_abnormal_imprinting | 1.97654295 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.95907232 |
| 21 | MP0005220_abnormal_exocrine_pancreas | 1.93296324 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.92251141 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.89762160 |
| 24 | MP0001661_extended_life_span | 1.86731348 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.85308717 |
| 26 | MP0004130_abnormal_muscle_cell | 1.85041582 |
| 27 | MP0003123_paternal_imprinting | 1.78586820 |
| 28 | MP0005360_urolithiasis | 1.77566817 |
| 29 | MP0004147_increased_porphyrin_level | 1.77031916 |
| 30 | MP0008995_early_reproductive_senescence | 1.73591998 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.71038465 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.70822551 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.67857023 |
| 34 | MP0002006_tumorigenesis | 1.63341445 |
| 35 | MP0003121_genomic_imprinting | 1.59902835 |
| 36 | MP0005187_abnormal_penis_morphology | 1.58949531 |
| 37 | MP0002009_preneoplasia | 1.54691934 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.49587487 |
| 39 | MP0003868_abnormal_feces_composition | 1.48834076 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.48496360 |
| 41 | MP0005408_hypopigmentation | 1.47949564 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.42445318 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.39492570 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.35042116 |
| 45 | MP0002971_abnormal_brown_adipose | 1.33006894 |
| 46 | MP0009115_abnormal_fat_cell | 1.32090977 |
| 47 | MP0001984_abnormal_olfaction | 1.31569874 |
| 48 | MP0010307_abnormal_tumor_latency | 1.29049244 |
| 49 | MP0003303_peritoneal_inflammation | 1.28824036 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 1.27885409 |
| 51 | MP0002269_muscular_atrophy | 1.27774499 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.26765312 |
| 53 | MP0002638_abnormal_pupillary_reflex | 1.23444879 |
| 54 | MP0003122_maternal_imprinting | 1.21947664 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.20538704 |
| 56 | MP0000609_abnormal_liver_physiology | 1.20419908 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.14360731 |
| 58 | MP0003943_abnormal_hepatobiliary_system | 1.12734656 |
| 59 | MP0004043_abnormal_pH_regulation | 1.11841097 |
| 60 | MP0003890_abnormal_embryonic-extraembry | 1.11561644 |
| 61 | MP0009697_abnormal_copulation | 1.09520937 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.07432868 |
| 63 | MP0008058_abnormal_DNA_repair | 1.05930610 |
| 64 | MP0002896_abnormal_bone_mineralization | 1.05918461 |
| 65 | MP0001873_stomach_inflammation | 1.03864835 |
| 66 | MP0005409_darkened_coat_color | 1.03572106 |
| 67 | MP0004484_altered_response_of | 1.03389568 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.03352304 |
| 69 | MP0001849_ear_inflammation | 1.02079220 |
| 70 | MP0005375_adipose_tissue_phenotype | 1.01939055 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.00966681 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.00905484 |
| 73 | MP0004134_abnormal_chest_morphology | 0.98883096 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98305923 |
| 75 | MP0002234_abnormal_pharynx_morphology | 0.97467227 |
| 76 | MP0009672_abnormal_birth_weight | 0.95863817 |
| 77 | MP0001666_abnormal_nutrient_absorption | 0.95757423 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.95640429 |
| 79 | MP0002088_abnormal_embryonic_growth/wei | 0.95182302 |
| 80 | MP0010630_abnormal_cardiac_muscle | 0.93771241 |
| 81 | MP0003984_embryonic_growth_retardation | 0.93553341 |
| 82 | MP0004947_skin_inflammation | 0.92646233 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.92493490 |
| 84 | MP0003195_calcinosis | 0.90951562 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.90854231 |
| 86 | MP0001879_abnormal_lymphatic_vessel | 0.90507187 |
| 87 | MP0001270_distended_abdomen | 0.89777364 |
| 88 | MP0003763_abnormal_thymus_physiology | 0.89075906 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.87421893 |
| 90 | MP0000537_abnormal_urethra_morphology | 0.86264954 |
| 91 | MP0000516_abnormal_urinary_system | 0.85846905 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.85846905 |
| 93 | MP0000427_abnormal_hair_cycle | 0.84085821 |
| 94 | MP0001299_abnormal_eye_distance/ | 0.83642342 |
| 95 | MP0008007_abnormal_cellular_replicative | 0.83057569 |
| 96 | MP0000733_abnormal_muscle_development | 0.80903905 |
| 97 | MP0005380_embryogenesis_phenotype | 0.80629809 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.80629809 |
| 99 | MP0000598_abnormal_liver_morphology | 0.80245373 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.79226765 |
| 101 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78869608 |
| 102 | MP0003436_decreased_susceptibility_to | 0.78845946 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.78626934 |
| 104 | MP0000685_abnormal_immune_system | 0.77838145 |
| 105 | MP0003091_abnormal_cell_migration | 0.77272251 |
| 106 | MP0009703_decreased_birth_body | 0.76419553 |
| 107 | MP0001727_abnormal_embryo_implantation | 0.76361256 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.76330923 |
| 109 | MP0004084_abnormal_cardiac_muscle | 0.76122869 |
| 110 | MP0005621_abnormal_cell_physiology | 0.75843690 |
| 111 | MP0004087_abnormal_muscle_fiber | 0.75690145 |
| 112 | MP0001697_abnormal_embryo_size | 0.74875244 |
| 113 | MP0002396_abnormal_hematopoietic_system | 0.73957552 |
| 114 | MP0003786_premature_aging | 0.73378249 |
| 115 | MP0000371_diluted_coat_color | 0.73358106 |
| 116 | MP0002106_abnormal_muscle_physiology | 0.72889496 |
| 117 | MP0001929_abnormal_gametogenesis | 0.72786308 |
| 118 | MP0002398_abnormal_bone_marrow | 0.72591557 |
| 119 | MP0002084_abnormal_developmental_patter | 0.72339264 |
| 120 | MP0001800_abnormal_humoral_immune | 0.71467763 |
| 121 | MP0000627_abnormal_mammary_gland | 0.71450029 |
| 122 | MP0005384_cellular_phenotype | 0.71436621 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.70834349 |
| 124 | MP0002098_abnormal_vibrissa_morphology | 0.70674943 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.70172285 |
| 126 | MP0001835_abnormal_antigen_presentation | 0.70153864 |
| 127 | MP0005334_abnormal_fat_pad | 0.69462343 |
| 128 | MP0004197_abnormal_fetal_growth/weight/ | 0.69223403 |
| 129 | MP0000266_abnormal_heart_morphology | 0.69146649 |
| 130 | MP0001915_intracranial_hemorrhage | 0.69067869 |
| 131 | MP0001545_abnormal_hematopoietic_system | 0.68431543 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.68431543 |
| 133 | MP0000703_abnormal_thymus_morphology | 0.67791334 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.67759986 |
| 135 | MP0001191_abnormal_skin_condition | 0.67116278 |
| 136 | MP0003718_maternal_effect | 0.65910664 |
| 137 | MP0002102_abnormal_ear_morphology | 0.65551682 |
| 138 | MP0005451_abnormal_body_composition | 0.65448657 |
| 139 | MP0003385_abnormal_body_wall | 0.65067275 |
| 140 | MP0002970_abnormal_white_adipose | 0.63587086 |
| 141 | MP0000653_abnormal_sex_gland | 0.62572785 |
| 142 | MP0004233_abnormal_muscle_weight | 0.62412979 |
| 143 | MP0001186_pigmentation_phenotype | 0.62286562 |
| 144 | MP0005083_abnormal_biliary_tract | 0.62005472 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.61833980 |
| 146 | MP0005253_abnormal_eye_physiology | 0.61221130 |
| 147 | MP0004924_abnormal_behavior | 0.60283055 |
| 148 | MP0005386_behavior/neurological_phenoty | 0.60283055 |
| 149 | MP0010368_abnormal_lymphatic_system | 0.59707445 |
| 150 | MP0002118_abnormal_lipid_homeostasis | 0.59607697 |
| 151 | MP0002086_abnormal_extraembryonic_tissu | 0.59102076 |
| 152 | MP0001845_abnormal_inflammatory_respons | 0.59013001 |
| 153 | MP0002925_abnormal_cardiovascular_devel | 0.58937201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Macroorchidism (HP:0000053) | 4.16035780 |
| 2 | Thyroid carcinoma (HP:0002890) | 4.07499225 |
| 3 | Ketoacidosis (HP:0001993) | 3.66749482 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.52419734 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.52419734 |
| 6 | Hepatoblastoma (HP:0002884) | 3.46068995 |
| 7 | Deep philtrum (HP:0002002) | 3.43953329 |
| 8 | Subacute progressive viral hepatitis (HP:0006572) | 3.42656262 |
| 9 | Hypoglycemic coma (HP:0001325) | 3.40783870 |
| 10 | Curly hair (HP:0002212) | 3.39241621 |
| 11 | Insidious onset (HP:0003587) | 3.24937561 |
| 12 | Termporal pattern (HP:0011008) | 3.24937561 |
| 13 | Hypoglycemic seizures (HP:0002173) | 3.22989493 |
| 14 | Pheochromocytoma (HP:0002666) | 3.20665933 |
| 15 | Cystic hygroma (HP:0000476) | 3.10599226 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.02984154 |
| 17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.00710962 |
| 18 | Hyperglycemia (HP:0003074) | 2.86243228 |
| 19 | Enlarged penis (HP:0000040) | 2.82877062 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 2.81233931 |
| 21 | Neuroendocrine neoplasm (HP:0100634) | 2.68204319 |
| 22 | Proximal tubulopathy (HP:0000114) | 2.66837488 |
| 23 | Lymphangioma (HP:0100764) | 2.62223737 |
| 24 | Poor coordination (HP:0002370) | 2.61172424 |
| 25 | Congenital primary aphakia (HP:0007707) | 2.60221467 |
| 26 | Ketosis (HP:0001946) | 2.58166966 |
| 27 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.55506070 |
| 28 | Short tibia (HP:0005736) | 2.53783938 |
| 29 | Overlapping toe (HP:0001845) | 2.53397302 |
| 30 | Abnormality of the fingertips (HP:0001211) | 2.50444314 |
| 31 | Gait imbalance (HP:0002141) | 2.48909578 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47519344 |
| 33 | Subaortic stenosis (HP:0001682) | 2.44771496 |
| 34 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.44771496 |
| 35 | Long toe (HP:0010511) | 2.44124912 |
| 36 | Aortic aneurysm (HP:0004942) | 2.42335628 |
| 37 | Hip dysplasia (HP:0001385) | 2.40350695 |
| 38 | Exostoses (HP:0100777) | 2.39868630 |
| 39 | Cerebral aneurysm (HP:0004944) | 2.39862507 |
| 40 | Hyperkalemia (HP:0002153) | 2.37772575 |
| 41 | Tubulointerstitial nephritis (HP:0001970) | 2.35676446 |
| 42 | Symptomatic seizures (HP:0011145) | 2.35501206 |
| 43 | Hematochezia (HP:0002573) | 2.35185554 |
| 44 | Cortical dysplasia (HP:0002539) | 2.34521130 |
| 45 | Widely spaced teeth (HP:0000687) | 2.34370381 |
| 46 | Breast carcinoma (HP:0003002) | 2.34179923 |
| 47 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30920089 |
| 48 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.30748718 |
| 49 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.30748718 |
| 50 | Fair hair (HP:0002286) | 2.28880438 |
| 51 | Myoglobinuria (HP:0002913) | 2.28313748 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.27839848 |
| 53 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.25136152 |
| 54 | Disinhibition (HP:0000734) | 2.24759991 |
| 55 | Agitation (HP:0000713) | 2.21642880 |
| 56 | Cutaneous melanoma (HP:0012056) | 2.21557897 |
| 57 | Striae distensae (HP:0001065) | 2.18035910 |
| 58 | Genital tract atresia (HP:0001827) | 2.16918029 |
| 59 | Renal cortical cysts (HP:0000803) | 2.15543435 |
| 60 | Neoplasm of the adrenal cortex (HP:0100641) | 2.15135785 |
| 61 | Acute myeloid leukemia (HP:0004808) | 2.11775883 |
| 62 | Drooling (HP:0002307) | 2.11149665 |
| 63 | Excessive salivation (HP:0003781) | 2.11149665 |
| 64 | Unilateral renal agenesis (HP:0000122) | 2.10320106 |
| 65 | Papilledema (HP:0001085) | 2.09051637 |
| 66 | Abnormal biliary tract morphology (HP:0012440) | 2.06305410 |
| 67 | Volvulus (HP:0002580) | 2.04902748 |
| 68 | Fatigue (HP:0012378) | 2.04839391 |
| 69 | Capillary hemangiomas (HP:0005306) | 2.04789817 |
| 70 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.04258201 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.02901027 |
| 72 | Inappropriate behavior (HP:0000719) | 2.02526248 |
| 73 | Large earlobe (HP:0009748) | 2.02045966 |
| 74 | Medulloblastoma (HP:0002885) | 2.01488806 |
| 75 | Heterotopia (HP:0002282) | 2.01213882 |
| 76 | Neoplasm of the thyroid gland (HP:0100031) | 2.01171729 |
| 77 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00745526 |
| 78 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.00574966 |
| 79 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.00574966 |
| 80 | Hyperventilation (HP:0002883) | 2.00444394 |
| 81 | Blue irides (HP:0000635) | 2.00427008 |
| 82 | Chronic hepatic failure (HP:0100626) | 1.99097663 |
| 83 | Aneurysm (HP:0002617) | 1.98605961 |
| 84 | Sandal gap (HP:0001852) | 1.98100294 |
| 85 | Viral hepatitis (HP:0006562) | 1.97244020 |
| 86 | Bladder carcinoma (HP:0002862) | 1.96695167 |
| 87 | Bladder neoplasm (HP:0009725) | 1.96695167 |
| 88 | Cubitus valgus (HP:0002967) | 1.96021312 |
| 89 | Abnormality of the common coagulation pathway (HP:0010990) | 1.95176453 |
| 90 | Papillary thyroid carcinoma (HP:0002895) | 1.93628757 |
| 91 | Deep venous thrombosis (HP:0002625) | 1.93319978 |
| 92 | Epidermoid cyst (HP:0200040) | 1.92885322 |
| 93 | Median cleft lip (HP:0000161) | 1.92500773 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 1.91013974 |
| 95 | Neoplasm of the small intestine (HP:0100833) | 1.90793221 |
| 96 | Entropion (HP:0000621) | 1.90653833 |
| 97 | Open mouth (HP:0000194) | 1.90284319 |
| 98 | Severe short stature (HP:0003510) | 1.90103743 |
| 99 | Submucous cleft hard palate (HP:0000176) | 1.88502648 |
| 100 | Neoplasm of the adrenal gland (HP:0100631) | 1.87174679 |
| 101 | Hypoplastic ischia (HP:0003175) | 1.86056515 |
| 102 | Vaginal atresia (HP:0000148) | 1.85931847 |
| 103 | Abnormality of the periventricular white matter (HP:0002518) | 1.85763366 |
| 104 | Neoplasm of the heart (HP:0100544) | 1.84205431 |
| 105 | Thin bony cortex (HP:0002753) | 1.84190972 |
| 106 | Narrow palate (HP:0000189) | 1.83847640 |
| 107 | Generalized hypopigmentation of hair (HP:0011358) | 1.83812945 |
| 108 | Abnormality of the ischium (HP:0003174) | 1.83099152 |
| 109 | Thoracolumbar scoliosis (HP:0002944) | 1.82578940 |
| 110 | Abnormality of the renal cortex (HP:0011035) | 1.80857301 |
| 111 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.79971410 |
| 112 | Broad palm (HP:0001169) | 1.79493341 |
| 113 | Micronodular cirrhosis (HP:0001413) | 1.78267455 |
| 114 | Asymmetry of the thorax (HP:0001555) | 1.78107304 |
| 115 | Thrombocytosis (HP:0001894) | 1.77658154 |
| 116 | Pulmonic stenosis (HP:0001642) | 1.77228183 |
| 117 | Central scotoma (HP:0000603) | 1.76137433 |
| 118 | Gonadotropin excess (HP:0000837) | 1.75896786 |
| 119 | Abnormal pancreas size (HP:0012094) | 1.75538421 |
| 120 | Hamartoma (HP:0010566) | 1.75372527 |
| 121 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.74606159 |
| 122 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.74098162 |
| 123 | Biliary tract neoplasm (HP:0100574) | 1.73850834 |
| 124 | Frequent falls (HP:0002359) | 1.72135612 |
| 125 | Hyperacusis (HP:0010780) | 1.71514467 |
| 126 | Osteomalacia (HP:0002749) | 1.70988962 |
| 127 | Colitis (HP:0002583) | 1.70929293 |
| 128 | Long clavicles (HP:0000890) | 1.70565719 |
| 129 | Spinal cord lesions (HP:0100561) | 1.69526934 |
| 130 | Syringomyelia (HP:0003396) | 1.69526934 |
| 131 | Obsessive-compulsive behavior (HP:0000722) | 1.68959093 |
| 132 | Hypobetalipoproteinemia (HP:0003563) | 1.68308036 |
| 133 | Rectal prolapse (HP:0002035) | 1.67767629 |
| 134 | Chorioretinal atrophy (HP:0000533) | 1.67684592 |
| 135 | Broad alveolar ridges (HP:0000187) | 1.67506951 |
| 136 | Cutis marmorata (HP:0000965) | 1.67442278 |
| 137 | Urinary urgency (HP:0000012) | 1.66460880 |
| 138 | Flat acetabular roof (HP:0003180) | 1.65770594 |
| 139 | Thick eyebrow (HP:0000574) | 1.65651103 |
| 140 | Abnormality of the gastric mucosa (HP:0004295) | 1.65375038 |
| 141 | Intrahepatic cholestasis (HP:0001406) | 1.64677510 |
| 142 | Hypoplastic labia majora (HP:0000059) | 1.64447245 |
| 143 | Pelvic girdle muscle weakness (HP:0003749) | 1.63779927 |
| 144 | Mucopolysacchariduria (HP:0008155) | 1.63524935 |
| 145 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.63524935 |
| 146 | Neoplasm of the oral cavity (HP:0100649) | 1.62985933 |
| 147 | Hypopigmentation of the fundus (HP:0007894) | 1.62759334 |
| 148 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.62360590 |
| 149 | Absent frontal sinuses (HP:0002688) | 1.62002548 |
| 150 | Truncal obesity (HP:0001956) | 1.61921075 |
| 151 | Prominent nasal bridge (HP:0000426) | 1.61806084 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61739834 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.61739834 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61739834 |
| 155 | Freckling (HP:0001480) | 1.60891467 |
| 156 | Verrucae (HP:0200043) | 1.60426489 |
| 157 | Papilloma (HP:0012740) | 1.60426489 |
| 158 | Skin nodule (HP:0200036) | 1.60160786 |
| 159 | Thickened nuchal skin fold (HP:0000474) | 1.60157675 |
| 160 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.60021150 |
| 161 | Rimmed vacuoles (HP:0003805) | 1.59222456 |
| 162 | Mitral stenosis (HP:0001718) | 1.59085012 |
| 163 | Dysmetric saccades (HP:0000641) | 1.59018915 |
| 164 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.58761603 |
| 165 | Abnormality of the anterior horn cell (HP:0006802) | 1.57954315 |
| 166 | Degeneration of anterior horn cells (HP:0002398) | 1.57954315 |
| 167 | Hemangiomatosis (HP:0007461) | 1.57664332 |
| 168 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.57424380 |
| 169 | Short 4th metacarpal (HP:0010044) | 1.57424380 |
| 170 | Absent eyebrow (HP:0002223) | 1.57116817 |
| 171 | Periodontitis (HP:0000704) | 1.56922762 |
| 172 | Coarse hair (HP:0002208) | 1.56727628 |
| 173 | Gaze-evoked nystagmus (HP:0000640) | 1.56641790 |
| 174 | Leiomyosarcoma (HP:0100243) | 1.55842460 |
| 175 | Uterine leiomyosarcoma (HP:0002891) | 1.55842460 |
| 176 | Elfin facies (HP:0004428) | 1.55457524 |
| 177 | Recurrent viral infections (HP:0004429) | 1.54330816 |
| 178 | Conjugated hyperbilirubinemia (HP:0002908) | 1.54023329 |
| 179 | Hamartoma of the eye (HP:0010568) | 1.53667091 |
| 180 | Bowel diverticulosis (HP:0005222) | 1.53380820 |
| 181 | Menstrual irregularities (HP:0000858) | 1.52925800 |
| 182 | Conjunctival hamartoma (HP:0100780) | 1.52423566 |
| 183 | Myocardial infarction (HP:0001658) | 1.51816001 |
| 184 | Mitral valve prolapse (HP:0001634) | 1.51592358 |
| 185 | Abnormality of oral frenula (HP:0000190) | 1.51419916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 3.58883250 |
| 2 | PKN2 | 3.43921385 |
| 3 | FRK | 3.04730729 |
| 4 | MAP3K10 | 2.96120131 |
| 5 | EIF2AK3 | 2.77324751 |
| 6 | TRIB3 | 2.74072132 |
| 7 | ERN1 | 2.57752617 |
| 8 | BCR | 2.43505785 |
| 9 | BRSK2 | 2.36316312 |
| 10 | INSRR | 2.36030884 |
| 11 | WNK3 | 2.17600020 |
| 12 | SIK1 | 2.09284396 |
| 13 | ACVR1B | 2.05004350 |
| 14 | TAOK3 | 2.01771886 |
| 15 | LATS1 | 2.01760457 |
| 16 | EEF2K | 1.88419638 |
| 17 | SCYL2 | 1.85147025 |
| 18 | PTK6 | 1.76531490 |
| 19 | CDK12 | 1.69190444 |
| 20 | TTN | 1.66218742 |
| 21 | STK38L | 1.63286296 |
| 22 | EIF2AK1 | 1.59729455 |
| 23 | FLT3 | 1.58986936 |
| 24 | ERBB3 | 1.56436120 |
| 25 | FGFR3 | 1.55910085 |
| 26 | JAK1 | 1.54565677 |
| 27 | FGFR2 | 1.53853607 |
| 28 | JAK3 | 1.53217537 |
| 29 | TYK2 | 1.52917931 |
| 30 | CAMK1D | 1.49386114 |
| 31 | OBSCN | 1.48360349 |
| 32 | MST4 | 1.47436799 |
| 33 | NEK6 | 1.45357999 |
| 34 | SRPK1 | 1.42989708 |
| 35 | TGFBR1 | 1.40470657 |
| 36 | HIPK2 | 1.36601590 |
| 37 | TGFBR2 | 1.31216737 |
| 38 | SIK2 | 1.30638350 |
| 39 | CAMK1G | 1.29634446 |
| 40 | RIPK1 | 1.29493908 |
| 41 | MAP3K2 | 1.29017807 |
| 42 | RET | 1.28632000 |
| 43 | PDGFRA | 1.27433823 |
| 44 | BMPR1B | 1.24104856 |
| 45 | CDK6 | 1.23132113 |
| 46 | FGFR4 | 1.18144583 |
| 47 | BRD4 | 1.15069775 |
| 48 | PRKD3 | 1.14519829 |
| 49 | DYRK1B | 1.11163154 |
| 50 | STK38 | 1.10865206 |
| 51 | PRKCH | 1.09766909 |
| 52 | MARK1 | 1.09548349 |
| 53 | LRRK2 | 1.08890642 |
| 54 | FER | 1.07331902 |
| 55 | TRPM7 | 1.05933322 |
| 56 | EPHA3 | 1.05338902 |
| 57 | YES1 | 1.03052357 |
| 58 | PIK3CA | 1.03042896 |
| 59 | JAK2 | 1.01496454 |
| 60 | CDK9 | 1.00939643 |
| 61 | PINK1 | 0.97683200 |
| 62 | PAK3 | 0.96638878 |
| 63 | STK10 | 0.96569435 |
| 64 | CAMKK2 | 0.91315425 |
| 65 | SIK3 | 0.87830619 |
| 66 | PASK | 0.86819731 |
| 67 | MAP3K14 | 0.86450735 |
| 68 | MTOR | 0.85694637 |
| 69 | NEK9 | 0.85089172 |
| 70 | MAP3K5 | 0.83420618 |
| 71 | SGK223 | 0.83274386 |
| 72 | SGK494 | 0.83274386 |
| 73 | STK3 | 0.82985972 |
| 74 | BMPR2 | 0.82833004 |
| 75 | MELK | 0.79785190 |
| 76 | KSR1 | 0.79206179 |
| 77 | SGK3 | 0.78710928 |
| 78 | PDK2 | 0.77832021 |
| 79 | MAP3K7 | 0.77600866 |
| 80 | MAPK11 | 0.76955135 |
| 81 | MAP2K7 | 0.74157780 |
| 82 | MAP3K6 | 0.73289891 |
| 83 | NTRK3 | 0.72787428 |
| 84 | NUAK1 | 0.72480547 |
| 85 | DYRK3 | 0.71398039 |
| 86 | WEE1 | 0.69765882 |
| 87 | MAPKAPK3 | 0.66721466 |
| 88 | PDGFRB | 0.65159263 |
| 89 | CAMK4 | 0.65147507 |
| 90 | MAP2K4 | 0.64591161 |
| 91 | PIM2 | 0.63788096 |
| 92 | ATM | 0.63452817 |
| 93 | ITK | 0.63350245 |
| 94 | TBK1 | 0.63246059 |
| 95 | MAP4K1 | 0.63131524 |
| 96 | PRKAA1 | 0.62506660 |
| 97 | PHKG1 | 0.61032016 |
| 98 | PHKG2 | 0.61032016 |
| 99 | KSR2 | 0.60460370 |
| 100 | LMTK2 | 0.60073820 |
| 101 | CAMKK1 | 0.55782123 |
| 102 | RAF1 | 0.52025870 |
| 103 | RPS6KB1 | 0.51556674 |
| 104 | CDC7 | 0.51169031 |
| 105 | PRKCE | 0.50347042 |
| 106 | TNIK | 0.50252264 |
| 107 | EIF2AK2 | 0.49721340 |
| 108 | STK24 | 0.49230153 |
| 109 | CSNK1G1 | 0.48846322 |
| 110 | CDK4 | 0.48729707 |
| 111 | EGFR | 0.48624775 |
| 112 | WNK1 | 0.47879182 |
| 113 | CSNK1A1L | 0.47210866 |
| 114 | FGFR1 | 0.47143980 |
| 115 | MAPK13 | 0.47130195 |
| 116 | PLK2 | 0.46812231 |
| 117 | SGK1 | 0.45531587 |
| 118 | DYRK1A | 0.45517796 |
| 119 | CLK1 | 0.44922594 |
| 120 | CASK | 0.44545763 |
| 121 | RPS6KA4 | 0.44516713 |
| 122 | MKNK1 | 0.43521978 |
| 123 | MARK2 | 0.43113279 |
| 124 | CHUK | 0.43029720 |
| 125 | CSNK1G3 | 0.42936106 |
| 126 | PRKAA2 | 0.42676376 |
| 127 | CSNK1G2 | 0.42632153 |
| 128 | MAP3K13 | 0.40132555 |
| 129 | NLK | 0.39328570 |
| 130 | RPS6KA2 | 0.38828926 |
| 131 | CSNK1D | 0.38826093 |
| 132 | SYK | 0.38721154 |
| 133 | ATR | 0.38667277 |
| 134 | MAPK10 | 0.38531992 |
| 135 | RPS6KB2 | 0.38496653 |
| 136 | GRK6 | 0.38027009 |
| 137 | PRKD1 | 0.38026748 |
| 138 | PDK1 | 0.37785508 |
| 139 | IRAK1 | 0.37493949 |
| 140 | IRAK2 | 0.37236041 |
| 141 | MAPK9 | 0.37200856 |
| 142 | MAP3K3 | 0.36977362 |
| 143 | MAP3K4 | 0.36845073 |
| 144 | SGK2 | 0.36765830 |
| 145 | PIK3CG | 0.35254288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.94794063 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05929328 |
| 3 | Insulin resistance_Homo sapiens_hsa04931 | 2.05183773 |
| 4 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 2.02696507 |
| 5 | Lysine degradation_Homo sapiens_hsa00310 | 1.87551267 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.86578814 |
| 7 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.84864386 |
| 8 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.84328784 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.77188374 |
| 10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.71136928 |
| 11 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.70467132 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66634900 |
| 13 | Endometrial cancer_Homo sapiens_hsa05213 | 1.64207670 |
| 14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.63539295 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.58062584 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.52711416 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51599394 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.44848002 |
| 19 | Colorectal cancer_Homo sapiens_hsa05210 | 1.44576752 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40355613 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.38708193 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38041777 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37815554 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33147082 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.29284999 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.28452527 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24054624 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.22801022 |
| 29 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.22366147 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20437456 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19452472 |
| 32 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19344957 |
| 33 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.18954915 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17214098 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16615678 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.15992555 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12493858 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11762555 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.10295373 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08783654 |
| 41 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.08446480 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.05875301 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04436643 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03612340 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03260784 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02717562 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01788490 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00284075 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97029113 |
| 50 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95539977 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95369158 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95237956 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94527193 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94130827 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94120472 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.93702511 |
| 57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93276573 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92857659 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92822780 |
| 60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.92194941 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91083563 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.90847532 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90786294 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88946060 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88140286 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87075519 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.85973072 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.85943632 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85514553 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.85213642 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82247103 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81519927 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80925465 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80799220 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80366673 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.80275592 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79153762 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77145994 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76656138 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76193650 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75738029 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75378359 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.74293449 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.73985407 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73897156 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72746417 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.72494484 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71947646 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.70680242 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.69643240 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69586347 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69500590 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.68436746 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67929263 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.67273621 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66254319 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65903027 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65322780 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65285958 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64949055 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.64386470 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64213005 |
| 103 | Cell cycle_Homo sapiens_hsa04110 | 0.63794463 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63734025 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63063420 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62864895 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62623883 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62458573 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62416836 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60731474 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59483276 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58935900 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58706039 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58516173 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56885365 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56241972 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55834575 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55113229 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.54982540 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54965019 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54768596 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53969990 |
| 123 | Melanoma_Homo sapiens_hsa05218 | 0.53860590 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53580151 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52899737 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.51887500 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51014007 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.50734965 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50555522 |
| 130 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50436205 |
| 131 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50311940 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50027104 |
| 133 | Renin secretion_Homo sapiens_hsa04924 | 0.49927920 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49743108 |
| 135 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49677093 |
| 136 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48864108 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.47115621 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.46527713 |
| 139 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43002495 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42392213 |
| 141 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39819724 |
| 142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38694317 |
| 143 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37342891 |

